Xcyton Diagnostics Private Limited

Xcyton Diagnostics Private Limited - healthcare in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN U33112KA1993PTC014776 Incorporated 30 September 1993 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company healthcare MSME · Micro
Data last updated
Revenue · FY 2025
₹1.59 Cr
▼ 85% YoY
Net loss · FY 2025
₹2.49 Cr
Net margin -156.5%
EBITDA · FY 2025
-₹2.36 Cr
EBITDA margin -148.2%
Authorised capital
₹3.6 Cr
Registered with MCA
Paid-up capital
₹1.98 Cr
Issued & subscribed
Open charges
₹1 Cr
Satisfied ₹1.46 Cr
Company age
33 yrs
Est. 1993
Employees · EPFO
23
Provident fund records

About Xcyton Diagnostics Private Limited

Data last updated:

Xcyton Diagnostics Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 30 September 1993 and has been in existence for over 33 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U33112KA1993PTC014776. Its GSTIN is 29AAACX0152B1ZS (Karnataka).

The company has an authorised share capital of ₹3.6 Cr and a paid-up capital of ₹1.98 Cr. It was formerly known as Xcyton Diagnostics Limited. It is led by directors Latha Padinjyaravedu and Venkata Ravikumar Banda.

Its last annual general meeting (AGM) was held on 14 November 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.449 10th Cross 4th Phase Peenya Industrial Area, Bangalore, Karnataka, India – 560058.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.59 Cr, a decline of 85% compared to the previous year. For the same year it recorded a net loss of ₹2.49 Cr (net margin -156.5%) and EBITDA of -₹2.36 Cr (EBITDA margin -148.2%). Revenue has declined at a compounded annual rate (CAGR) of 37% over three years and 18% over five years.

The company has about 23 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: XCyton Diagnostics. As per MCA filings, the company has open charges of ₹1 Cr and satisfied charges of ₹1.46 Cr on record. Court records list 6 cases involving the company, including 3 filed by the company and 3 filed against it; 1 case is pending. The company has 7 deals on record (5 funding rounds, 2 secondary share transfers), with disclosed funding of ₹11.86 Cr; the latest was in March 2019. The company has 6 MSME Form 1 returns on record between 2020 and 2024, listing 34 overdue payments to 10 micro and small suppliers.

Xcyton Diagnostics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0143293). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website xcyton.com.

Company details

CIN U33112KA1993PTC014776
Registration Number 014776
Incorporation Date 30 September 1993
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 14 November 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0143293

CIN history

Xcyton Diagnostics has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U33112KA1993PTC014776, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U33112KA1993PTC014776Current
U33112KA1993PLC014776Previous
U85110KA1993PTC014776Previous

Recognitions & Rankings of Xcyton Diagnostics

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-KR-03-0143293

Contact details

Xcyton Diagnostics Private Limited's registered office is in Bangalore, Karnataka. Its website is xcyton.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Social Media
  • Registered Address
    No.449 10th Cross 4th Phase Peenya Industrial Area, Bangalore, Karnataka, India – 560058
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs

To see the full contact details of Xcyton Diagnostics Private Limited, buy the company report.

Comprehensive company report
Xcyton Diagnostics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Xcyton Diagnostics operates one associated brand: XCyton Diagnostics. Each brand links to its own profile.

BrandDescriptionWebsite
Provider of molecular diagnostic products and servicesxcyton.com

Business activity

The main business activity of Xcyton Diagnostics is professional, scientific and technical. In detail, this covers scientific research and development.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM5Scientific research and development

To see the full business activity and turnover split of Xcyton Diagnostics Private Limited, buy the company report.

Financials of Xcyton Diagnostics Private Limited

FY 2025 filings available

Xcyton Diagnostics Private Limited reported revenue of ₹1.59 Cr (down 85% YoY) for FY 2025.

Revenue · FY 2025
₹1.59 Cr ▼ 85%
Net loss · FY 2025
₹2.49 Cr margin -156.5%
EBITDA · FY 2025
-₹2.36 Cr margin -148.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 85%
3 years · compounded
▼ 37%
5 years · compounded
▼ 18%
EBITDA CAGR growth
1 year
▼ 137%
3 years · compounded
▼ 60%
5 years · compounded
▼ 33%

Revenue has declined at a compounded annual rate (CAGR) of 18% over five years, including a 85% fall in the latest year. EBITDA fell 137% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹2.36 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹2.49 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-148.2%
Net Profit Margin-156.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Xcyton Diagnostics Private Limited, buy the company report.

Board of directors of Xcyton Diagnostics Private Limited

Xcyton Diagnostics has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Latha PadinjyaraveduDirector15 Jul 200125 Years 3 MonthsCurrent
Venkata Ravikumar BandaDirector30 Sep 199333 Years 1 MonthsCurrent

Auditor

Xcyton Diagnostics Private Limited is audited by SRIDHAR & BRITO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
SRIDHAR & BRITOFY 2023003987S

Shareholding

The shareholding of Xcyton Diagnostics Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Xcyton Diagnostics Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1 Cr
Satisfied charges
₹1.46 Cr
Breakdown by lending institutions
State Bank of India₹1.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Mar 2016100063448State Bank of India₹1 CrOpen
24 Aug 200490192858State Bank of Mysore₹30 LakhSatisfied
20 Mar 199890191927Centre for Technology Development₹20 LakhSatisfied
31 Oct 199690194051Canara Bank₹25.5 LakhSatisfied
19 May 199590191440Small Industries Development Bank of India₹70 LakhSatisfied

To see the full charge records of Xcyton Diagnostics Private Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Xcyton Diagnostics Private Limited has 7 deals on record (5 funding rounds, 2 secondary share transfers), with disclosed funding of ₹11.86 Cr; the latest was in March 2019.

Total deals
7
Funding rounds
5
Secondary share transfers
2
Disclosed funding
₹11.86 Cr

Deals on record (5 of 7)

WhenDealAmountParties
Sep 2014Funding round₹1 CrInvestors: Eight Roads Ventures
Nov 2011Funding round₹6.7 CrInvestors: Eight Roads Ventures
Mar 2011Secondary share transferUndisclosedBuyer: Nadathur Holdings
Seller: an individual
Jan 2011Funding round₹35.5 LakhInvestors: Birthstone Capital, an individual
Mar 2007Funding round₹92.8 LakhInvestors: 4 individuals

To see the full deal history of Xcyton Diagnostics Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Xcyton Diagnostics Private Limited has 6 MSME Form 1 returns on record between 2020 and 2024, listing 34 overdue payments to 10 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 10)

SupplierAmount dueDue sinceReported on
M/Shuwel Lifesciences Pvt Ltd., Telangana
Ultra Cal, Bangalore
an individual supplier
DSS Takara Bio India Private Limited
Everon Life Sciences, Delhi

To see the full MSME payment records of Xcyton Diagnostics Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Xcyton Diagnostics Private Limited has a workforce of 23 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.

Employee count
23
Active EPFO establishments
1
Employee growth
-8%

GST

Xcyton Diagnostics has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
29AAACX0152B1ZSKarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Xcyton Diagnostics Private Limited, buy the company report.

Recent activity

Xcyton Diagnostics Private Limited has 9 board changes on record since 1993: 2 appointments and 7 cessations. The latest: Latha Padinjyaravedu ceased to be Whole-Time Director on 30 Mar 2025.

AGM
Xcyton Diagnostics Private Limited last Annual general meeting of members was held on 14 Nov 2025 as per latest MCA records.
Filing
Xcyton Diagnostics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Latha Padinjyaravedu ceased to be Whole-Time Director.
Ceased
Venkata Ravikumar Banda ceased to be Managing Director.
Charges
A charge with State Bank Of India of Rs. 1.00 Cr registered on 30 Mar 2016 with Charge ID 100063448 was modified on 05 Dec 2022.
Charges
A charge with State Bank Of India amounted to Rs. 1.00 Cr with Charge ID 100063448 was registered on 30 Mar 2016.
Charges
A charge registered on 24 Aug 2004 via Charge ID 90192858 with State Bank Of Mysore was fully satisfied on 15 Apr 2015.
Ceased
Robert Mark Weisskoff ceased to be Director.
Ceased
Prem Venkatachalam Pavoor ceased to be Alternate Director.
Ceased
Rajesh Kumar Dugar ceased to be Director.
Ceased
Rajesh Kumar Dugar ceased to be Director.
Ceased
Sarangarajan Varadachari ceased to be Additional Director.

12 earlier events are in the company report.

Frequently asked questions

Xcyton Diagnostics is an active private limited company based in Bangalore, Karnataka, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 30 September 1993 (33+ years old) and is registered under CIN U33112KA1993PTC014776.

Xcyton Diagnostics has 2 current directors:

The latest financial statements of Xcyton Diagnostics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 14 November 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Xcyton Diagnostics is 29AAACX0152B1ZS, registered in Karnataka.

The CIN (Corporate Identification Number) of Xcyton Diagnostics is U33112KA1993PTC014776. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Xcyton Diagnostics has 6 court cases on record: 3 filed by the company and 3 filed against it. 1 is pending.

Xcyton Diagnostics was incorporated on 30 September 1993, making it 33+ years old. It is registered with the Registrar of Companies, Bangalore.

Xcyton Diagnostics has 7 deals on record (5 funding rounds, 2 secondary share transfers), with disclosed funding of ₹11.86 Cr; the latest was in March 2019.

Latha Padinjyaravedu ceased to be Whole-Time Director on 30 Mar 2025. Venkata Ravikumar Banda ceased to be Managing Director on 30 Mar 2025. Robert Mark Weisskoff ceased to be Director on 26 Jun 2014. Xcyton Diagnostics has 9 board changes on record in total.

Yes, Xcyton Diagnostics is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0143293).

Xcyton Diagnostics has 6 MSME Form 1 returns on record between 2020 and 2024, listing 34 overdue payments to 10 micro and small suppliers. The latest return was filed on 23 Apr 2024.